Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Valdis Ģībietis"'
Autor:
Marte A.M. van Hylckama Vlieg, Kazem Nasserinejad, Chantal Visser, Wichor M. Bramer, Aneel A. Ashrani, Jean-Luc Bosson, Daniel J. Crusan, Andrea D'Alessio, Meg E. Fluharty, Valdis Ģībietis, Per-Olof Hansson, Nobuhiro Hara, Luis Jara-Palomares, Noémie Kraaijpoel, Isabelle Mahé, Andrea Marshall, Yutaka Ogino, Remedios Otero, Jorie Versmissen, Frederikus A. Klok, Marieke J.H.A. Kruip, Carin C.D. van der Rijt, Eric C.T. Geijteman
Publikováno v:
EClinicalMedicine, Vol 64, Iss , Pp 102194- (2023)
Summary: Background: The optimal duration of anticoagulation in patients with active cancer and venous thromboembolism (VTE) is unknown. Current clinical guidelines advocate anticoagulant therapy for 3–6 months and to continue anticoagulant therapy
Externí odkaz:
https://doaj.org/article/0b244b1247b14396920dccd8d33a5371
Autor:
Valdis Ģībietis
Publikováno v:
Medicina, Vol 59, Iss 4, p 771 (2023)
A 66-year-old female patient was hospitalized with severe COVID-19 pneumonia, which led to hypoxia requiring oxygen support with high-flow nasal cannulae. She received anti-inflammatory treatment with a 10-day dexamethasone 6 mg PO course and a singl
Externí odkaz:
https://doaj.org/article/e116f692346c46f98d65fd614008164b
Autor:
Valdis Ģībietis, Dana Kigitoviča, Sintija Strautmane, Kitija Meilande, Verners Roberts Kalējs, Anastasija Zaičenko, Kristīne Maķe, Aivars Lejnieks, Andris Skride
Publikováno v:
Medicina, Vol 55, Iss 9, p 510 (2019)
Background and objectives: Recurrence of venous thromboembolism (VTE) after a primary event is common; however, no sufficient risk scores have been widely introduced in clinical practice. The aim of this study was to assess the risk factors for VTE r
Externí odkaz:
https://doaj.org/article/d5df251f7b614169a1500aa3ebdaebe5
Publikováno v:
Medical Principles and Practice. 28:264-272
Background: In-hospital mortality for patients presenting with acute pulmonary embolism (PE) has been reported to be up to 7 times higher for patients with decreased estimated glomerular filtration rate (eGFR). However, few studies have assessed its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0183ca35eecf3a44317176efc057515e
https://doi.org/10.1159/000497436
https://doi.org/10.1159/000497436
Publikováno v:
Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 28(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2119ea8ccec711e812e3365894082a1
https://pubmed.ncbi.nlm.nih.gov/30991385
https://pubmed.ncbi.nlm.nih.gov/30991385
Publikováno v:
Gut Microbes, Vol 15, Iss 1 (2023)
ABSTRACTClostridioides difficile infections (CDI) are a leading cause of healthcare-associated infections with a high relapse rate. Current treatment guidelines recommend fidaxomicin as the primary therapy for initial CDI episodes and suggest alterna
Externí odkaz:
https://doaj.org/article/af4e3a8427134f23a968cd1c670d72b7
Autor:
Dana Kigitoviča, Kristīne Maķe, Valdis Ģībietis, Aivars Lejnieks, Kitija Meilande, Sintija Strautmane, Verners Roberts Kalējs, Anastasija Zaičenko, Andris Skride
Publikováno v:
Medicina; Volume 55; Issue 9; Pages: 510
Medicina
Volume 55
Issue 9
Medicina, Vol 55, Iss 9, p 510 (2019)
Medicina
Volume 55
Issue 9
Medicina, Vol 55, Iss 9, p 510 (2019)
Background and objectives: Recurrence of venous thromboembolism (VTE) after a primary event is common
however, no sufficient risk scores have been widely introduced in clinical practice. The aim of this study was to assess the risk factors for V
however, no sufficient risk scores have been widely introduced in clinical practice. The aim of this study was to assess the risk factors for V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8e9c5da45eec707bc56592dc87d852b
https://doi.org/10.3390/medicina55090510
https://doi.org/10.3390/medicina55090510